SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001654954-19-008227
Filing Date
2019-07-12
Accepted
2019-07-12 17:20:49
Documents
4
Period of Report
2019-09-05

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY PROXY STATEMENT vtgnpre14a_sep052019.htm PRE 14A 1189912
2 IMAGE sig1.jpg GRAPHIC 3796
3 IMAGE sig2.jpg GRAPHIC 3612
4 IMAGE vtgnlogo.jpg GRAPHIC 7061
  Complete submission text file 0001654954-19-008227.txt   1211332
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
VistaGen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: PRE 14A | Act: 34 | File No.: 001-37761 | Film No.: 19953606
SIC: 2834 Pharmaceutical Preparations